EGFR and lung adenocarcinoma: Additionally, podoplanin-positive CAFs have been implicated in EGFR TKI resistance in EGFR-mutant lung adenocarcinoma, as evidenced by in vitro studies showing that cancer cells co-cultured with these CAFs exhibit increased resistance [150].